ArticleBMC infectious diseases2025
Prevalence of exotoxin and type III secretion system genes in multidrug-resistant Pseudomonas aeruginosa isolates from patients with burn injuries in Southern Iran.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPseudomonas aeruginosa is a leading cause of burn wound infections, with pathogenicity driven by exotoxins and the Type III Secretion System (T3SS). Among its components, ExoA, ExoT, and the popB gene (T3SS translocon) are particularly associated with acute tissue damage and treatment failure.
methodsIn this cross-sectional study (March 2021–March 2022), 108 non-duplicate, drug-resistant P. aeruginosa isolates were collected from burn patients at Amir-Al-Momenin Hospital, Shiraz. PCR assays detected exoA, exoT, exoS, exoU, exoY, and T3SS (popB). Antimicrobial susceptibility testing was performed according to CLSI 2022 guidelines, with MIC determination for colistin and imipenem. MDR was defined as resistance to ≥ 3 antibiotic classes.
resultsAmong the detected genes, exoA (81.5%) and exoT (77.8%) were the most prevalent, followed by exoY (68.5%) and T3SS (popB) (66.7%), while exoS (63.9%) and exoU (46.3%) were less frequent. Isolates carrying T3SS (popB) showed significantly higher resistance to multiple antibiotics compared to T3SS (popB) negative isolates (p < 0.05). MIC analysis demonstrated preserved susceptibility to colistin (MIC50 = 0.25 µg/mL, MIC90 = 0.5 µg/mL) but high imipenem resistance (MIC50 = 32 µg/mL, MIC90 = 64 µg/mL).
conclusionExoA and ExoT were the most prevalent exotoxin genes, while the T3SS (popB) gene, although slightly less frequent, showed a strong association with multidrug resistance. These findings highlight the clinical relevance of these virulence determinants, particularly popB, and support further investigation into T3SS-targeted therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.